Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Favipiravir Tablets

Approval Number

国药准字H20203029

Company浙江海正药业股份有限公司

Registration Date

February 15, 2020

Drug Information

Generic Name

法维拉韦片

Brand Name

海复康

Dosage Form

片剂

Strength

0.2g

Drug Type

化学药品

Registration Date

February 15, 2020

Company Information

Applicant Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省台州市椒江区外沙路46号

Manufacturing Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省台州市椒江区外沙路46号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy